- Home
- ECDA vs LPCN Comparison
ECDA vs LPCN Comparison
Compare ECDA & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECDA
- LPCN
- Stock Information
- Founded
- ECDA 2013
- LPCN 1997
- Country
- ECDA United States
- LPCN United States
- Employees
- ECDA N/A
- LPCN N/A
- Industry
- ECDA Auto Manufacturing
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- ECDA Consumer Discretionary
- LPCN Health Care
- Exchange
- ECDA Nasdaq
- LPCN Nasdaq
- Market Cap
- ECDA 43.3M
- LPCN 36.8M
- IPO Year
- ECDA N/A
- LPCN N/A
- Fundamental
- Price
- ECDA $1.03
- LPCN $5.73
- Analyst Decision
- ECDA Strong Buy
- LPCN Strong Buy
- Analyst Count
- ECDA 1
- LPCN 1
- Target Price
- ECDA $9.00
- LPCN $10.00
- AVG Volume (30 Days)
- ECDA 16.4K
- LPCN 22.7K
- Earning Date
- ECDA 11-15-2024
- LPCN 11-06-2024
- Dividend Yield
- ECDA N/A
- LPCN N/A
- EPS Growth
- ECDA N/A
- LPCN N/A
- EPS
- ECDA N/A
- LPCN N/A
- Revenue
- ECDA $25,728,409.00
- LPCN $4,800,930.00
- Revenue This Year
- ECDA $125.56
- LPCN N/A
- Revenue Next Year
- ECDA $36.05
- LPCN N/A
- P/E Ratio
- ECDA N/A
- LPCN N/A
- Revenue Growth
- ECDA 123.27
- LPCN 8630.55
- 52 Week Low
- ECDA $0.75
- LPCN $2.31
- 52 Week High
- ECDA $17.00
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- ECDA 40.78
- LPCN 71.60
- Support Level
- ECDA $1.03
- LPCN $4.89
- Resistance Level
- ECDA $1.14
- LPCN $5.30
- Average True Range (ATR)
- ECDA 0.06
- LPCN 0.39
- MACD
- ECDA -0.01
- LPCN 0.05
- Stochastic Oscillator
- ECDA 0.00
- LPCN 92.55
About ECDA ECD Automotive Design Inc.
ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the most customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.